Tocqueville Asset Management L.P. Acquires Shares of 301,191 CVS Health Corporation $CVS

Tocqueville Asset Management L.P. bought a new position in CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 301,191 shares of the pharmacy operator’s stock, valued at approximately $31,158,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Addison Advisors LLC purchased a new position in shares of CVS Health in the 2nd quarter worth about $41,000. Mmbg Investment Advisors CO. bought a new position in CVS Health in the 2nd quarter worth about $722,000. West Family Investments Inc. purchased a new stake in CVS Health during the 2nd quarter valued at about $176,000. NewEdge Wealth LLC bought a new stake in CVS Health during the 2nd quarter valued at about $2,166,000. Finally, Empirical Asset Management LLC purchased a new position in CVS Health in the second quarter worth about $566,000. 80.66% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Royal Bank Of Canada upped their target price on shares of CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. JPMorgan Chase & Co. raised their price target on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Barclays upped their price objective on CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Wall Street Zen upgraded CVS Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. Finally, Mizuho lifted their target price on CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Price Performance

Shares of CVS Health stock opened at $93.58 on Thursday. The stock has a market cap of $119.68 billion, a P/E ratio of 24.76, a P/E/G ratio of 0.91 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The stock’s fifty day moving average is $102.32 and its 200 day moving average is $88.69. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. During the same quarter in the previous year, the company posted $1.81 earnings per share. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio is currently 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.